Summary of the April 2016 meeting of the Strategic Advisory Group of Experts on immunization
WHO SAGE Meeting, Geneva: 12 – 14 April 2016 :: 4 pages
[Summary Section Headings]
:: Dengue Vaccine [recommendation]
:: Polio Eradication [IVP and OPV2 withdrawal]
:: Pre-empting and responding to vaccine supply shortages
:: Missed opportunities for vaccination
:: Other Issues
* Implementation Research as part of vaccine program development
* Immunization-specific indicator in the SDG Indicator Framework
* RSV (respiratory syncytial virus) vaccine pipeline,
* Immunization in the context of HSS and UHC
* New “second-year-of-life” immunization platform

New recommendations for dengue vaccine
6 April 2016 — Dengue is the world’s most extensively spread mosquito-borne virus – in the last 60 years, global incidence of the disease has increased 30-fold. The WHO Strategic Advisory Group of Experts (SAGE) on immunization has recommended that a vaccine for dengue, called Dengvaxia (CYD-TDV), be considered for use in geographic settings with high endemicity.